Sign up to save your podcasts
Or
Share Koi & Cannabis
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Koi & Cannabis
What if the next medical cannabis breakthrough wasn't in a lab but in a basement with 3,000 koi? In this episode we trace how Aqualitas created an aquaponic ecosystem that caught the eye of a global cannabis distributer and helped them transform their business.
Episode breakdown & timestamps:
00:00 — Opening: The unlikely origins of big medical innovation (intro to the central mystery and stakes).
02:20 — From hockey rinks to hedge funds to cannabis: Josh Roberts' journey and why Wellford pursued Aqualitas (founder & investor perspective).
06:30 — Meet the scientist: Danielle Maitland explains aquaponics vs hydroponics and the living ecosystem that fuels plants.
10:15 — Inside Aqualitas: the basement system, 3,000 koi, recirculating aquaculture, and the water chemistry that changes product quality.
13:30 — Business & science meet: why aquaponics creates a defensible moat, R&D hurdles, and the global response.
16:30 — Takeaways, implications for sustainable cultivation, and what's next for Nova Scotia's life sciences scene.
Guest bios & credentials:
- Danielle Maitland — Director of Science & Cultivation Technology, Aqualitas. Background: chemical engineering, MSc in sustainable aquaculture, PhD candidate in agricultural sciences; expert in aquaponics and plant–microbe interactions.
- Josh Roberts — Chief Business Officer, Wellford Group. Former hedge fund trader and co-founder of Cannaray/Wellford
What you'll learn:
- How aquaponics works and why it can outperform hydroponics for cannabis: closed-loop water, nutrient cycling, and beneficial microbes.
- The sustainability gains: 90–95% water recirculation, reduced synthetic fertilizers, and lower energy/resource footprint.
- Commercial and regulatory implications: why unique cultivation methods create supply-chain advantages and differentiation for medical cannabis.
- Lessons for founders and investors: the power of deep R&D, place-based innovation (Nova Scotia), and vertical integration strategies.
Resources & links mentioned:
- Aqualitas: https://aqualitas.ca
- Wellford Group / Cannaray: https://wellford.com
- Life Sciences Nova Scotia: https://lifesciencesnovascotia.ca
- Snack Labs: https://wearesnack.io
- Intro reading on aquaponics vs hydroponics: https://en.wikipedia.org/wiki/Aquaponics
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By Snack LabsWhat if the next medical cannabis breakthrough wasn't in a lab but in a basement with 3,000 koi? In this episode we trace how Aqualitas created an aquaponic ecosystem that caught the eye of a global cannabis distributer and helped them transform their business.
Episode breakdown & timestamps:
00:00 — Opening: The unlikely origins of big medical innovation (intro to the central mystery and stakes).
02:20 — From hockey rinks to hedge funds to cannabis: Josh Roberts' journey and why Wellford pursued Aqualitas (founder & investor perspective).
06:30 — Meet the scientist: Danielle Maitland explains aquaponics vs hydroponics and the living ecosystem that fuels plants.
10:15 — Inside Aqualitas: the basement system, 3,000 koi, recirculating aquaculture, and the water chemistry that changes product quality.
13:30 — Business & science meet: why aquaponics creates a defensible moat, R&D hurdles, and the global response.
16:30 — Takeaways, implications for sustainable cultivation, and what's next for Nova Scotia's life sciences scene.
Guest bios & credentials:
- Danielle Maitland — Director of Science & Cultivation Technology, Aqualitas. Background: chemical engineering, MSc in sustainable aquaculture, PhD candidate in agricultural sciences; expert in aquaponics and plant–microbe interactions.
- Josh Roberts — Chief Business Officer, Wellford Group. Former hedge fund trader and co-founder of Cannaray/Wellford
What you'll learn:
- How aquaponics works and why it can outperform hydroponics for cannabis: closed-loop water, nutrient cycling, and beneficial microbes.
- The sustainability gains: 90–95% water recirculation, reduced synthetic fertilizers, and lower energy/resource footprint.
- Commercial and regulatory implications: why unique cultivation methods create supply-chain advantages and differentiation for medical cannabis.
- Lessons for founders and investors: the power of deep R&D, place-based innovation (Nova Scotia), and vertical integration strategies.
Resources & links mentioned:
- Aqualitas: https://aqualitas.ca
- Wellford Group / Cannaray: https://wellford.com
- Life Sciences Nova Scotia: https://lifesciencesnovascotia.ca
- Snack Labs: https://wearesnack.io
- Intro reading on aquaponics vs hydroponics: https://en.wikipedia.org/wiki/Aquaponics
Hosted on Acast. See acast.com/privacy for more information.